Table 2.
Dead space variables, blood gas analysis and compliance during the decremental PEEP trial | ||||||||
---|---|---|---|---|---|---|---|---|
PEEP (cm H2O) | 14 | 12 | 10 | 8 | 6 | 4 | 2 | 0 |
VT (ml) | 472 (80) | 476 (77) | 474 (80) | 473 (77) | 472 (76) | 471 (78) | 474 (81) | 473 (81) |
VDaw (ml) | 214 (40) | 209 (42) | 204 (39) | 196 (40)* | 188 (39) | 182 (36) | 174 (32) | 167 (26) |
VDalv (ml) | 52 (37) | 52 (34) | 47 (31) | 45 (33) | 42 (33)* | 35 (32) | 39 (31) | 35 (29) |
VDBohr/VT | 0.48 (0.06) | 0.47 (0.07) | 0.45 (0.07)* | 0.43 (0.07) | 0.40 (0.07) | 0.38 (0.07) | 0.35 (0.07) | 0.33 (0.07) |
VDEnghoff/VT | 0.57 (0.07) | 0.55 (0.08) | 0.53 (0.08)* | 0.52 (0.08) | 0.49 (0.08) | 0.47 (0.09) | 0.46 (0.08) | 0.44 (0.08) |
VDalv/VTalv | 0.19 (0.11) | 0.18 (0.1) | 0.17 (0.09) | 0.15 (0.09) | 0.14 (0.1)* | 0.12 (0.1) | 0.13 (0.09) | 0.11 (0.09) |
SnIII (mm Hg ml−1) | 0.95 (1.19) | 0.73 (0.64) | 0.62 (0.31) | 0.62 (0.43) | 0.58 (0.33) | 0.48 (0.25)* | 0.47 (0.26) | 0.50 (0.21) |
VTCO2,br (ml) | 12.5 (3.3) | 13.3 (3.7)* | 13.9 (3.7) | 14.3 (3.6) | 14.7 (3.7) | 15.2 (3.7) | 15.7 (3.8) | 16.0 (3.9) |
VIII/VT | 0.42 (0.14) | 0.39 (0.13) | 0.41 (0.14) | 0.43 (0.13)* | 0.46 (0.13) | 0.46 (0.13) | 0.48 (0.12) | 0.51 (0.11) |
Pa-ETCO2 (mm Hg) | 3.6 (2.8) | 3.4 (2.5) | 3.7 (2.6) | 3.2 (2.5) | 2.9 (2.7) | 2.7 (2.4) | 3.1 (2.4) | 2.8 (2.5)* |
(mm Hg) | 43 (5) | 43 (5) | 44 (5) | 43 (5) | 42 (5) | 42 (5) | 42 (5) | 41 (5)* |
(mm Hg) | 138 (35) | 140 (32) | 145 (25) | 145 (24) | 145 (23) | 139 (21) | 132 (24) | 127 (23)* |
(mm Hg) | 346 (87) | 349 (80) | 359 (71) | 371 (71) | 372 (68) | 357 (65) | 338 (72) | 324 (70)* |
Dynamic compliance (ml cm H2O−1) | 34 (6) | 36 (8) | 35 (6) | 35 (7) | 35 (7) | 34 (7) | 33 (7) | 31 (7)* |